<DOC>
	<DOCNO>NCT00703248</DOCNO>
	<brief_summary>Treatment option increase immune function , Osteopathic Manipulation Treatment ( OMT ) lymphatic technique , may provide improve short long term performance immune system . However , efficacy OMT boost immune function among people live HIV yet examine control study . Our experiment design examine short ( 45 minute ) term impact OMT white blood cell count HIV positive men either antiretroviral therapy ( ART ) naïve take ART least 12 month prior enrollment study .</brief_summary>
	<brief_title>The Human Immunodeficiency Virus Osteopathic Manipulation Evaluation Study</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>either Antiretroviral Therapy ( ART ) naïve take ART past 12 month age 18 65 CD4+ T cell count 200700cells/mm3 viral load le 100,000 copies/mL medical condition limit ability participate study define physician ( e.g. , cancer , blood clot disorder etc . ) willing provide inform consent use drug recreationally prescribe systemic steroid willing recruit friend/partner , aware HIV serostatus , train OMT technique apply daily . history malignancy exclude squamous cell carcinoma basal cell carcinoma skin and/or malignancy fully treat consider cured treat physician least 1 year aortic aneurism/disease vertebral artery disease carotid artery stenosis/disease abdominal hernia portal hypertension cirrhosis cervical disc disease currently exhibit radicular symptomatology ( i.e . numbness , burning , muscle weakness , etc ) infectious mononucleosis past 12 week , pneumothorax bone disease Participants medical access port and/or noncompliant ribcage exclude study . The potential cause ribcage noncompliance include : congestive obstructive pulmonary disorder ( COPD ) spinal arthritis costochondritis congestive heart failure ( CHF ) pulmonary edema recent trauma ribcage certain connective tissue disease Ankylosing Spondylitis There risk abdominal aortic aneurysm ( AAA ) rupture participant AAA participant exclude study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Human Immunodeficiency Virus ( HIV )</keyword>
	<keyword>complementary therapy</keyword>
</DOC>